An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non–muscle-invasive bladder cancer: Interim…

Overview of attention for article published in Urologic Oncology, July 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#13 of 2,928)
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 19,269 followers.

Interim results of the CG0070 oncolytic virus regimen for #BladderCancer have been published in UrolOnc https://t.co/JR3X56snqs ^LS

RT @UroOncDC: Promising early results in BCG-unresponsive #bladdercancer. Great work! https://t.co/r9mMgG6XJZ

Promising early results in BCG-unresponsive #bladdercancer. Great work! https://t.co/r9mMgG6XJZ

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.